KEGG pathway analysis showed that gene sets related to p53 pathway were significantly enriched among genes up-regulated in PBRM1-deficient cells compared to 786-O control cells treated with Fdcyd (Figures 3A, B), suggesting that tumor cell death under Fdcyd treatment may due to the activation of p53 signaling pathway. Here, TP53 is linked to neoplasm.